Clinical Trials
7 trialsNCT06540937 2024-08-07
Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT00001277 2022-06-07
Studies of Elevated Parathyroid Activity
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00514046 2020-12-22
Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT00325104 2017-07-02
Cinacalcet to Treat Familial Primary Hyperparathyroidism
National Institutes of Health Clinical Center (CC)
Phase 3 Completed
NCT00947167 2017-03-03
A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors
Stanford University
Phase 2 Terminated
NCT00204373 2012-10-30
Treatment of Zollinger-Ellison Syndrome With Prevacid
University of Alabama at Birmingham
Phase 4 Completed
NCT00990535 2009-10-07
HIDONET
Federico II University
Phase 2 Completed